The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation is moving closer to fulfilling Prime Minister Narendra Modi's goal of ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors ...

CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing ...

ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101  BERLIN, Germany and BRUSSELS, Belgium, December 09, 2025 / Biotech ...

This large-scale genomic analysis of 14 psychiatric disorders shows that most heritable risk is shared across five broad ...

STK-012 is an α/β biased IL-2 partial agonist designed to stimulate antigen-activated T cells while avoiding IL-2 associated toxicities Positive Phase 1b data recently presented at SITC 2025, with a ...

A massive genomic study of over 1 million cases found that shared risk across 14 psychiatric disorders is reduced to 5 ...

The Conejo Valley’s life science moment is here — driven by global leaders, emerging innovators, modern infrastructure, and a skilled workforce.

Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics, has closed an oversubscribed $6.6 million seed ...

An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the ...